Abstract
5-HT4 receptors in isolated distal colon myenteric plexus of guinea-pig, mediating contraction of longitudinal smooth muscle, have been further characterized by selective agonists and antagonists. The indole agonists, 5-HT and 5-methoxytryptamine (5-MeOT), were full agonists (relative to 5-HT) with potency values (pEC50) of 8.0 ± 0.1 (n = 50) and 7.8 ± 0.1 (n = 12), respectively. 5-HT4 receptor agonists of other structural classes, including benzimidazolones (BIMU 1 and BIMU 8), and benzamides ((S)-zacopride, (R)-zacopride, renzapride, SC 49518) were partial agonists with intrinsic activities less than that of 5-HT. In general, the potencies for these compounds at 5-HT4 receptors in guinea-pig colon were similar to the potencies seen in the rat isolated oesophagus, where 5-HT4 receptors mediate relaxation.
GR 113808 {[1-[2-[(methylsulfonyl)amino]ethyl]-4-piperidinyl]methyl1-methyl-1H-indole-3-carboxylat}, RS 39604 {1-[4-amino-5-chloro-2-(3,5-dimethoxybenzyloxy)phenyl]-3-[1-[2-[(methylsulfonyl)amino] ethyl]-4-piperidinyl]-1-propanone hydrochloride and SB 204070 {(1-n-butyl-4-piperidinyl)methyl 8-amino-7-chloro-1,4-benzodioxane-5-carboxylate} antagonized 5-HT responses with pA2 values of 9.1 ± 0.1, 9.0 ± 0.2 and 11.0 ± 0.1, respectively. These affinity values were similar to those obtained at 5-HT4 receptors in isolated rat oesophagus (9.0 ± 0.4, 9.3 ± 0.1 and 10.6 ± 0.1, respectively).
Despite these operational similarities between 5-HT4 receptors in guinea-pig colon and rat oesophagus, several novel compounds have revealed important differences between 5-HT4 receptors in the two tissues. For example, the substituted benzoate, RS 23597 {3-(piperidine-1-yl) propyl-4-amino-5-chloro-2-methoxybenzoate hydrochloride, acted as a partial agonist (intrinsic activity 0.5) in guinea-pig colon with a potency of 7.6 ± 0.1 (n = 16). In isolated rat oesophagus, however, this compound was a surmountable antagonist (pA2 = 7.8 ± 0.1) with no intrinsic activity. In contrast, the substituted naphthalimide (S)RS 56532 {(S)6-amino-5-chloro-2-(1-azabicyclo[2, 2, 2]octan-3-yl)2,3-dihydro-1H-benz isoquinoline-1,3-dione hydrochloride}, was a potent (pEC50 = 7.9 ± 0.1), efficacious partial agonist (intrinsic activity = 0.8) in the rat oesophagus. However, in guinea-pig colon, it was a surmountable antagonist with an affinity (pKB) of 9.4 ± 0.1. Furthermore, several novel, selective, 5-HT4 compounds also showed opposing patterns of intrinsic activities similar to those described for RS 23597 and (S)RS 56532.
It is concluded that these differences are inconsistent with differences in 5-HT4 receptor reserves, and may suggest that 5-HT4 receptors in the guinea-pig colon and the rat oesophagus can be operationally distinguished.
Similar content being viewed by others
References
Adham N, Gerald C, Schechter LE, Weinshank RL Branchek TA (1994) [3H]5-HT labels the high affinity state of the cloned rat 5-HT4 receptor. Third IUPHAR satellite meeting on serotonin. Abstract number 55
Adham N, Gerald C, Vaysse PJJ, Weinshank RL, Branchek A (1995) Characterization of the functional responses mediated by two splice variants of the cloned rat 5-HT4 receptor in heterologus expression systems. Br J Pharmacol 114:158P
Arunlakshana O, Schild NO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58
Baxter GS, Craig DA, Clarke DE (1991) 5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae. Naunyn-Schmiedeberg's Arch Pharmacol 343:439–446
Bockaert J, Sebben M, Dumuis A (1990) Pharmacological characterization of 5-HT4 receptors positively coupled to adenylate cyclase in adult guinea-pig hippocampal membranes: effects of substituted benzamide derivatives. Mol Pharmacol 37:408–411
Briejer MR, Akkermans LMA, Schuurkes JAJ (1995) Gastrointestinal prokinetic benzarnides: the pharmacology underlying stimulation of motility. Pharmacol Rev 47:631–651
Cheng Y-C, Prusoff WH (1973) Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Clark RD, Weinhardt KK, Berger J, Lee CH, Leung E, Wong EHF, Smith WL, Eglen RM (1993) N-(quinuclidin-3-yl)-1,8-naphthalimides with 5-HT3 receptor antagonist and 5-HT4 receptor agonist properties. BioOrg Med Chem Lett 3:1375–1378
Clark RD, Jahangir A, Langston JA, Weinhardt KK, Miller AB, Leung E, Eglen RM (1994a) Ketones related to the benzoate 5-HT4 receptor antagonist RS-23597 are high affinity partial agonists. BioOrg Med Chem Lett 4:2477–2480
Clark RD, Jahangir A, Langston JA, Weinhardt KK, Miller AB, Leung E, Bonhaus DW, Wong EHF, Eglen RM (1994b) Synthesis and preliminary pharmacological evaluation of 2-Benzyloxy substituted aryl ketones as 5-HT4 receptor antagonists. BioOrg Med Chem Lett 4:2481–2484
Clark RD, Muchowski JM, Weinhardt KK, Dillon MP, Lee CH, Bley KR, Bonhaus DW, Wong EHF, Eglen RM (1995) N-(quinuclidin-3-y1)-2-(1-methyl-1H-indol-3-yl)-2-oxo-acetamide: a high affinity 5-HT3 receptor partial agonist. BioOrg Med Chem Lett 5:1853–1856
Craig DA, Clarke DE (1990) Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea-pig ileum with properties similar to the 5-hydroxytryptamine4 receptor. J Pharmacol Exp Ther 252:1378–1385
Craig DA, Eglen RM, Walsh LKM, Perkins LA, Whiting RL, Clarke DE (1990) 5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine desensitization as discriminative tools for the 5-HT3 and putative 5-HT4 receptors in guinea-pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 342:9–16
Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J (1988) A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34:880–887
Dumuis A, Sebben M, Bockaert J (1989) The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn-Schmiedeberg's Arch Pharmacol: 340:403–410
Eglen RM, Swank SR, Walsh LKM, Whiting RL (1990) Characterization of 5-HT3 and ‘atypical’ 5-HT receptors mediating guinea-pig ileal contractions in vitro. Br J Pharmacol 101:513–520
Eglen RM, Perkins LA, Walsh LKM, Whiting RL (1992) Agonist action of indole derivatives at 5-HT1-likes 5-HT3, and 5HT4 receptors in vitro. J Anton Pharmacol 12:321–333
Eglen RM, Alvarez R, Johnson LG, Leung E, Wong EH (1993a) The action of SDZ 205,557 at 5-hydroxytryptamine (5-HT3 and 5-HT4) receptors. Br J Pharmacol 108:376–382
Eglen RM, Bley K, Bonhaus DW, Clark RD, Hegde SS, Johnson LG, Leung E, Whiting RL (1993b) RS-23597–190: a potent and selective 5-HT4 receptor antagonist. Br J Pharmacol 110:119–126
Eglen RM, Bonhaus DW, Clark RD, Johnson LG, Lee C-H, Leung E, Smith WL, Wong EHF, Whiting RL (1994) (R) and (S) RS 56532: Mixed 5-HT3 and 5-HT4 receptor ligands with opposing enantiomeric selectivity. Neuropharmacology 33:515–526
Eglen RM, Bonhaus DW, Clark RD, Johnson LG, Leung E (1995a) RS-17017, RS-67333 and RS-67506: Potent and selective 5-HT4 receptor partial agonists in vitro and in vivo. Br J Pharmacol 114:159P
Eglen RM, Bonhaus DW, Johnson LG, Leung E, Clark RD (1995b) Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo. Br J Pharmacol 115:1387–1392
Elswood CJ, Bunce KT, Humphrey PPA (191) Identification of 5-HT4 receptors in guinea-pig ascending colon. Eur J Pharmacol 196:149–155
Ford APDW, Clarke DE (1993) The 5-HT4 receptor. Med Res Rev 13:633–662
Ford APDW, Baxter GS, Eglen RM, Clarke DE (1992) 5-Hydroxytryptamine stimulates cyclic AMP formation in the tunica muscularis mucosae of the rat oesophagus via 5-HT4 receptors. Eur J Pharmacol 211:117–120
Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blashko H, Muscholl E (eds) Handbook of experimental pharmacology, Catecholamines, vol 33. Springer, New York, pp 283–335
Gale JD, Grossman CJ, Whitehead JWF, Oxford AW, Bunce KT, Humphrey PPA (1994) GR113808: a novel selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol 111:332–338
Gerald C, Adham N, Kao HT, Olsen MA, Laz TM, Schechter LE, Bard JA, Vaysse PJJ, Hartig PR, Branchek TA, Weinshank RL (1995) The 5-HT4 receptor — molecular cloning and pharmacological characterization of two splice variants. EMBO J 14:2806–2815
Gullikson GW, Virina MA, Loeffler RF, Yang DC, Goldstin B, Wang S-X, Moummi C, Flynn DL, Zabrowski DL (1993) SC49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism. J Pharmacol Exp Ther 264:240–248
Hegde SS, Bonhaus DW, Johnson LG, Leung E, Clark RD, Eglen RM (1995) RS 39604: A potent, selective and orally active 5-HT4 receptor antagonist. Br J Pharmacol 115:1087–1095
Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) VII. International Union of Pharmacology Classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 46:157–203
Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1990) A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol 100:879–885
Kenakin T (1995a) Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol Sci 16:188–192
Kenakin T (1995b) Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol Sci 16:232–238
Kilbinger H, Gebauer A, Haas J, Ladinsky H, Rizzi CA (1995) Benzimidazolones and renzapride facilitate acetylcholine release from guinea-pig myenteric plexus via 5-HT4 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 351:229–236
Leung E, Michelson S, Villarubia C, Perkins LA, Eglen RM (1992) Analysis of concentration-response relationships by seemingly unrelated nonlinear regression (SUNR) technique. J Pharmacol Methods 28:209–216
Leung E, Pulido-Rios MT, Wong EHF and Eglen RM (1995) Characterization of 5-hydroxytryptamine (5-HT)4 receptors in guinea pig distal colon. FASEB J 9: Abstract number 5538, A954
McLean PG, Coupar IM (1995) 5-HT4 receptor antagonist affinities of SB 204070, SB 205008, and SB 203186 in the human colon, rat oesophagus, and guinea-pig ileum peristaltic reflex. Naunyn-Schmiedeberg's Arch Pharmacol 252:132–140
McLean PG, Coupar IM, Molenaar P (1995) A comparative study of 5-HT4 receptors in human colon, rat oesophagus and rat ileum. Br J Pharmacol 115:47–56
Medhurst AD, Kaumann AJ (1993) Characterization of the 5-HT4 receptor mediating tachycardia in piglet isolated right atrium. Br J Pharmacol 110:1023–1030
Milligan G (1993) Mechanisms of multifunctional signalling by G-protein-linked receptors. Trends Pharmacol Sci 14:239–244
Parker RB, Wand DR (1971) Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther 177:1–12
Reynolds GP, Mason SL, Meldrum A, De Keczer S, Parnes H, Eglen RM, Wong EHF (1995) 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerate diseases. Br J Pharmacol 114:993–998
Rizzi CA, Coccini T, Onori L, Manzo L, Tonini M (1992) Benzimidazolone derivatives: A new class of 5-hydroxytryptamine4 receptor agonists with prokinetic and acetylcholine releasing properties in the guinea-pig ileum. J Pharmacol Exp Ther 261:412–419
Sanger GJ (1987) Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924. Br J Pharmacol 91:77–87
Tam FS-F, Hillier K, Bunce KT, Grossman C (1995) Differences in response to 5-HT4 receptor agonists and antagonists of the 5-HT4-like receptor in human colon circular smooth muscle. Br J Pharmacol 115:172–176
Waikar MV, Hegde SS, Ford APDW, Clarke DE (1993) Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo [3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H-benzimidazole-l-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat oesophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine. J Pharmacol Exp Ther 264:654–661
Wardle KA, Sanger GJ (1993) The guinea-pig distal colon — a sensitive preparation for the investigation of 5-HT4 receptor-mediated contractions. Br J Pharmacol 110:1593–1599
Wardle KA, Ellis ES, Baxter GS, Kennett GA, Gaster LM, Sanger GJ (1994) The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon. Br J Pharmacol 112:789–794
Wong EHF, Hsu S, Leung E, Berger J, Clark R, Bonhaus DW, Eglen RM (1995) Labelling 5-HT4 receptors with a novel agonist radioligand, [3H]RS 57639-190. J Neurochem 65:S26B
Zeitung KD, Perkins LA, Hsu SAO, Bonhaus DW, Eglen RM, Wong EHF, Leung E (1994) Comparison of GR 113808 and SB 204070 at 5-HT4 receptors in vitro. FASEB J 8: Abstract no. 533, A92
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leung, E., Pulido-Rios, M.T., Bonhaus, D.W. et al. Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 354, 145–156 (1996). https://doi.org/10.1007/BF00178714
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00178714